Calamos Advisors’s Templeton Emerging Markets Fund EMF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$955K Buy
42,898
+2,682
+7% +$59.2K ﹤0.01% 784
2026
Q2
$934K Sell
40,216
-4,975
-11% -$108K ﹤0.01% 764
2026
Q1
$790K Buy
45,191
+5,380
+14% +$102K ﹤0.01% 826
2025
Q4
$678K Buy
39,811
+15,750
+65% +$268K ﹤0.01% 732
2025
Q3
$403K Buy
24,061
+4,295
+22% +$66.2K ﹤0.01% 788
2025
Q2
$288K Sell
19,766
-1,718
-8% -$22.7K ﹤0.01% 794
2025
Q1
$276K Sell
21,484
-859
-4% -$10.9K ﹤0.01% 773
2024
Q4
$267K Buy
22,343
+4,295
+24% +$55.4K ﹤0.01% 782
2024
Q3
$244K Sell
18,048
-6,720
-27% -$85.2K ﹤0.01% 779
2024
Q2
$306K Buy
24,768
+7,855
+46% +$94.9K ﹤0.01% 744
2024
Q1
$202K Buy
+16,913
New +$195K ﹤0.01% 773

Other funds holding EMF

Calamos Advisors's EMF Position: Q3 2026 in Review

Calamos Advisors increased its Templeton Emerging Markets Fund (EMF) stake by 6.7% in Q3 2026, buying an estimated $59.2K and bringing the position to 42,898 shares worth $955K. The position accounts for ﹤0.01% of the portfolio, ranked #784.

Calamos Advisors first reported a position in EMF in Q1 2024 and has held it in 11 quarters since. 33 funds tracked by Wall St. Rank hold EMF as of Q3 2026.

  • Calamos Advisors held 42,898 shares of Templeton Emerging Markets Fund worth $955K as of Q3 2026.
  • Calamos Advisors bought 2,682 Templeton Emerging Markets Fund shares in Q3 2026, an estimated $59.2K.
  • Templeton Emerging Markets Fund made up ﹤0.01% of Calamos Advisors's portfolio in Q3 2026, its #784 holding.
  • Calamos Advisors first reported a position in Templeton Emerging Markets Fund in Q1 2024 and has held it in 11 quarters since.
  • 33 funds tracked by Wall St. Rank held Templeton Emerging Markets Fund as of Q3 2026.

Based on Calamos Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.